Page 30 - IPO Tracker

Snapdeal parent AceVector files updated DRHP for ₹300 cr IPO; OFS included

AceVector plans to deploy the net proceeds towards marketing and business promotion

Ecom firms eye the next 500 million shoppers, chase Meesho's playbook

The Indian consumers' focus on value has pushed Amazon to develop tools such as value dashboards and gamified in-app experiences - innovations now being adopted in other markets

Investing in Nephrocare Health IPO? Check 5 key risks before you decide

Nephrocare Health IPO will be offered at a price band of ₹438 to ₹460 per share and a lot size of 32 shares

Corona Remedies IPO off to a lukewarm start; GMP holds steady at 27%

Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here

Subscribed to Aequs IPO? Here's how to check allotment status, latest GMP

Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

Wakefit Innovations IPO opens today: Check GMP, price band, dates, review

Ahead of its IPO, Wakefit Innovations raised ₹580 crore from 33 institutional investors via an anchor book on December 5

Meesho IPO subscribed 79x; check allotment status, GMP, listing date

Meesho IPO allotment: Applicants can verify their status through the NSE and BSE websites or by visiting the IPO registrar, Kfin Technologies

ICICI Prudential AMC to launch IPO on Dec 12 as Prudential sells 10% stake

Prudential will sell up to 49 million shares in the IPO, compared with an earlier plan of 17.7 million shares, ICICI Prudential said in a filing late on Friday

Meesho, Aequs, and Vidya Wires IPOs overall bid exceeds ₹3 trillion

Meesho, Aequs and Vidya Wires drew bids worth nearly Rs 3 trillion, with institutional investors driving subscriptions as high as 120 times the shares on offer

Mainboard IPOs score a century for the first time after 18 years

Riding on favourable valuations, strong DII participation, IPO proceeds to cross ₹1.7 trn mark

Last day to bid for Vidya Wires IPO: Check subscription status, GMP

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

IPO Calendar: D-Street braces for 9 new issues; Meesho, Aequs listings

IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore

Last day! Aequs IPO closes today; subscription rises 28x, GMP at 37%

Aequs IPO subscription status: Among the investor categories, retail investors led the demand, with the portion reserved for them subscribed by 56.62 times

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Park Medi World IPO opens Dec 10; sets price band at ₹154-162: Key details

Park Medi World is eyeing ₹770 crore through the fresh issue for 47.5 million equity shares, and shareholders will be selling 9.3 million equity shares through an OFS for ₹150 crore

Manipal Health readies $1 bn IPO; targets $12-15 bn valuation

Valuation of India's largest hospital network is around $12-15 bn. The Issue will comprise fresh issue of shares and a small portion as OFS

NephroPlus plans global scale-up ahead of IPO amid rising CKD burden

India's largest dialysis provider plans to expand clinics at home and abroad ahead of its December 10 IPO, betting on rising CKD burden and demand for accessible dialysis care

Corona Remedies IPO opens Dec 8: GMP at 31%; 5 key risks you should know

Corona Remedies IPO will be offered at a price band of ₹1,008 to ₹1,062 per share, with a lot size of 14 shares

Meesho IPO booked 3x on strong demand; should you bid too? Analysts weigh

Analysts highlight Meesho's zero-commission, asset-light business model, coupled with its multi-sided marketplace and logistics network